Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Rotavirus vaccines: development, current issues and future prospects.

Nigel A Cunliffe1, Joseph S Bresee, C Anthony Hart

  • 1Department of Medical Microbiology and Genito-Urinary Medicine, University of Liverpool, Duncan Building, Daulby Street, Liverpool L69 3GA, UK. n.a.cunliffe@liv.ac.uk

The Journal of Infection
|September 10, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cost-Effective Threshold Price for Alternative Infant and Neonatal Rotavirus Vaccines: A Dual-Country Evaluation.

medRxiv : the preprint server for health sciences·2026
Same author

Risk factors associated with Shigella diarrhea in 6-35-month-olds: A cross-sectional study, Malawi, 2022-2024.

PLOS global public health·2026
Same author

The incidence and antimicrobial resistance of Shigella-attributable diarrhoea in young children in low-income and middle-income countries from the multicountry Enterics for Global Health (EFGH) Shigella Surveillance Study: a prospective, facility-based hybrid surveillance study.

The Lancet. Global health·2026
Same author

The Third Study of Infectious Intestinal Disease (IID3 Study) in the Community: Protocol for UK-Based Prospective Cohort Studies Investigating the Disease Burden.

JMIR research protocols·2026
Same author

COVID-19 vaccine acceptance and recommendation among health workers in nine countries: a pooled analysis of survey data from 2023 to 2024.

BMJ global health·2026
Same author

Prevalence and molecular epidemiology of rotavirus gastroenteritis among children in Nairobi's urban informal settlements following introduction of the Rotavac® vaccine.

Tropical medicine and health·2026
Same journal

Landscape and ecological correlates of tick-associated viruses in Inner Mongolia, China.

The Journal of infection·2026
Same journal

Age-associated impairment of humoral and cellular immune responses to SARS-CoV-2 in a large community cohort with hybrid immunity.

The Journal of infection·2026
Same journal

Genomic characterization of a large-scale chikungunya outbreak in China.

The Journal of infection·2026
Same journal

Convergent neutralizing antibodies to SARS-CoV-2 variants over 2.5 years after BA.5/BF.7 breakthrough infection.

The Journal of infection·2026
Same journal

Multi-strain Clostridioides difficile infection: Increased detection and clinical implications.

The Journal of infection·2026
Same journal

A randomised comparison of management strategies for drug-induced liver injury associated with tuberculous meningitis treatment.

The Journal of infection·2026
See all related articles

Rotavirus vaccines offer significant benefits for reducing child mortality in developing nations. However, safety and cost concerns remain barriers to widespread rotavirus vaccine adoption globally.

Area of Science:

  • Pediatrics
  • Vaccinology
  • Public Health

Background:

  • Rotavirus gastroenteritis is a major cause of child mortality globally, particularly in developing countries.
  • Rotavirus vaccines have demonstrated efficacy in reducing disease burden.
  • Recent safety concerns have impacted vaccine deployment in developed nations.

Purpose of the Study:

  • To evaluate the role and challenges of rotavirus vaccination in both developing and developed countries.
  • To address the ongoing considerations for rotavirus vaccine implementation.

Main Methods:

  • Review of existing literature on rotavirus vaccine efficacy, safety, and cost-effectiveness.
  • Analysis of the impact of vaccine withdrawal on global public health strategies.

Related Experiment Videos

Main Results:

  • Rotavirus vaccines are crucial for reducing child morbidity and mortality in resource-limited settings.
  • Cost-effectiveness has driven vaccine introduction in developed countries.
  • Intussusception reports led to vaccine withdrawal, shifting focus back to developing countries.

Conclusions:

  • Despite proven benefits, challenges in rotavirus vaccine safety, efficacy, and cost persist.
  • Overcoming these hurdles is essential for the anticipated widespread introduction of rotavirus vaccines.
  • Continued research and monitoring are vital for safe and effective rotavirus vaccine programs.